Navigation Links
NIAID researchers show how promising TB drug works

Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have determined how a promising drug candidate attacks the bacterium that causes tuberculosis (TB). Published online this week in Proceedings of the National Academy of Sciences, the finding may help scientists optimize the drug candidate, PA-824, which targets Mycobacterium tuberculosis (M. tb).

"PA-824, now in early stage clinical trials, holds promise for shortening the TB treatment regimen, which is currently cumbersome and lengthy," says NIAID Director Anthony S. Fauci, M.D. "This new finding will allow a streamlined approach for making improved versions of the drug."

"Previously, we were flying blind in trying to optimize PA-824 in a rational way because we didn't know which M. tb protein was the target of PA-824's action," says NIAID scientist Clifton Barry, III, Ph.D., who headed the research team.

In preclinical testing, PA-824 showed evidence of being effective against both actively dividing and slow-growing M. tb, giving rise to optimism that the compound may be useful in treating both active and latent TB. (For information about the first clinical trial of PA-824, see June 14, 2005, NIAID press release: http://www3.niaid.nih.gov/news/newsreleases/2005/tb_pa_824.htm.)

PA-824 must be chemically activated in the bacterium before it exerts its anti-tubercular effect, notes Dr. Barry. Earlier research had sketched out the first few steps in this process, but Dr. Barry and his colleagues wanted to pinpoint the precise protein that binds PA-824 and transforms it into a lethal molecule for TB.

The scientists approached the problem indirectly by searching for M. tb mutants that resisted the killing power of PA-824. The team confirmed previous research suggesting that resistance usually occurs when M. tb lacks components
'"/>

Source:NIH/National Institute of Allergy and Infectious Diseases


Page: 1 2 3

Related biology news :

1. NIAID Initiates Trial of Experimental Avian Flu Vaccine
2. NIAID begins clinical trial of West Nile virus vaccine
3. New NIAID grants strengthen national biodefense and emerging infectious diseases research network
4. NIAID DNA vaccine for H5N1 avian influenza enters human trial
5. NIAID expands capability for influenza research and surveillance
6. NYU researchers simulate molecular biological clock
7. Vital step in cellular migration described by UCSD medical researchers
8. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
9. UCSD researchers maintain stem cells without contaminated animal feeder layers
10. Why do insects stop breathing? To avoid damage from too much oxygen, say researchers
11. New protein discovered by Hebrew University researchers
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NIAID researchers show how promising drug works

(Date:7/23/2014)... The planet,s soil releases about 60 billion tons of ... more than that released by burning fossil fuels. This ... release of carbon is balanced by carbon coming into ... matter, as well as by the underground activities of ... that rising temperatures increase the rate of soil respiration. ...
(Date:7/23/2014)... in German . ... drive metabolic processes and transmit signals. To perform these ... at the Max Planck Institute for Developmental Biology in ... of similar amino acid chains even when their three-dimensional ... exist today arose from common precursors. Presumably, in the ...
(Date:7/23/2014)... megacephala is commonly found in dead bodies and ... of death, referred to as the post mortem interval. ... megacephala from Tamil Nadu is provided for the ... through generation of DNA barcoding. This study, significant in ... Biodiversity Data Journal . , Chrysomya megacephala ...
Breaking Biology News(10 mins):Climate change and the soil 2Protein evolution follows a modular principle 2Dead body feeding larvae useful in forensic investigations 2
... that snakes can optimize their vision by controlling the blood ... Kevin van Doorn, PhD, and Professor Jacob Sivak, from the ... blood flow patterns change depending on what,s in its environment. ... Journal of Experimental Biology . "Each species, perception ...
... If cats really had nine lives, one reason might be ... threaten feline health. Yunjeong Kim, a research assistant professor ... has developed a research approach that tackles two deadly infectious ... supported by a $156,342 award from the Morris Animal Foundation. ...
... Whitehead Institute scientists report that the gene mutated ... syndrome also prevents activation of mTORC1, a critical nutrient-sensing ... is an unexpected finding, as some cancers keep this ... expansion. In the case of Birt-Hogg-Dub syndrome, the mutated ...
Cached Biology News:Snakes control blood flow to aid vision 2College of Veterinary Medicine researcher doubles down on deadly, infectious cat diseases 2College of Veterinary Medicine researcher doubles down on deadly, infectious cat diseases 3Gene responsible for hereditary cancer syndrome found to disrupt critical growth-regulating pathway 2
(Date:7/22/2014)... -- Neogen Corporation (NASDAQ: NEOG ) announced today ... May 31, increased 19% from the previous year to ... the prior year,s $27,190,000. Adjusted for a 3-for-2 stock ... the current year were $0.76, compared to $0.75 a ... 2014 fiscal year established new all-time highs for the ...
(Date:7/22/2014)... e SHENZHEN , Cina, 22 ... (BGI Tech), una filiale di BGI, la maggiore organizzazione ... di un nuovo servizio di sequenziamento dell,intero esoma umano ... Genomics. Complete Genomics, molto apprezzata nel ... sequenziamento proprietarie con il 99.999% di precisione e una ...
(Date:7/22/2014)... SHENZHEN, China , July 22, 2014 /PRNewswire/ ... a subsidiary of BGI, the world,s largest genomics ... new human whole exome sequencing service based on ... includes in-depth bioinformatics analysis and SNP validation, and ... 2014. Complete Genomics, highly regarded ...
(Date:7/22/2014)... In chemical and petrochemical plants, ... sight. The rapid rise of TDL analyzers over ... as a core gas measurement technology, and their ... the gas analyzer technology of choice for many ... some processes have limited their application range. METTLER ...
Breaking Biology Technology:Neogen reports 19% increase in annual revenues 2Neogen reports 19% increase in annual revenues 3Neogen reports 19% increase in annual revenues 4Neogen reports 19% increase in annual revenues 5Neogen reports 19% increase in annual revenues 6Neogen reports 19% increase in annual revenues 7Neogen reports 19% increase in annual revenues 8BGI Tech lancia un servizio di sequenziamento dell'intero esoma umano sulla piattaforma avanzata di Complete Genomics 2BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 2BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 3METTLER TOLEDO Shows How Tunable Diode Lasers (TDLs) Can Be Installed Where No TDLs Have Gone Before 2
... insurance premiums have increased approximately 113% over the past ... by the Kaiser Family Foundation, the reverse is true ... demonstrably cheaper over the past 25 years, due primarily ... competitive market pressures. In addition, many new enhancements to ...
... March 1, 2012 The second phase of ... Healthy Weight," is being announced today by the ... partnership with the Health Resources and Services Administration ... community leaders, from Pasadena to Philadelphia, have been ...
... 2012  AtheroNova Inc. (OTCBB: AHRO), a biotech company focused ... atherosclerotic plaque, today announced that it has initiated the ... its research and development partner CardioNova, Ltd., a Russia ... human clinical studies of AHRO-001. The clinical-grade material will ...
Cached Biology Technology:WestPark Capital's Michael Wechsler Comments on the Life Insurance Market 2Groundbreaking National Program to Reverse Obesity Expands to 50 Locations 2AtheroNova Achieves Milestone in Initiating First Shipment of AHRO-001 2AtheroNova Achieves Milestone in Initiating First Shipment of AHRO-001 3
[14C]Polyethylene glycol 4000, 9.25 MBq, 250 uCi. Aqueous solution containing 3% ethanol, sterilized. 370-740 MBq/g, 10-20 mCi/g.1.85 MBq/ml, 50 uCi/ml. Category: Radiochemicals &Radiation Safety, ...
... Complete kit for all types of ... , Choice of ... of self-activating baits , ... stringency , Complete ...
Mouse Limitin MAb (Clone 183727)...
sterile filtered, off the clot, all male donors, Total Protein: 4.5 to 8.5 g/dl...
Biology Products: